Does REPOTRECTINIB Cause Neuropathy peripheral? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Neuropathy peripheral have been filed in association with REPOTRECTINIB (Augtyro). This represents 5.9% of all adverse event reports for REPOTRECTINIB.
11
Reports of Neuropathy peripheral with REPOTRECTINIB
5.9%
of all REPOTRECTINIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Neuropathy peripheral From REPOTRECTINIB?
Of the 11 reports, 2 (18.2%) required hospitalization.
Is Neuropathy peripheral Listed in the Official Label?
Yes, Neuropathy peripheral is listed as a known adverse reaction in the official FDA drug label for REPOTRECTINIB.
What Other Side Effects Does REPOTRECTINIB Cause?
Dizziness (32)
Death (21)
Nausea (12)
Adverse event (11)
Off label use (10)
Paraesthesia (10)
Balance disorder (9)
Pain (9)
Hospitalisation (8)
Muscular weakness (8)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which REPOTRECTINIB Alternatives Have Lower Neuropathy peripheral Risk?
REPOTRECTINIB vs REQUIP
REPOTRECTINIB vs RESLIZUMAB
REPOTRECTINIB vs RESMETIROM
REPOTRECTINIB vs RESTASIS
REPOTRECTINIB vs RETINOL